Clinical Trials Directory

Trials / Completed

CompletedNCT00852969

Niacin and Endothelial Function in Early CKD

Does Raising HDL-C With Niacin Improve Endothelial Function in Early CKD?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Tufts Medical Center · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to obtain information on whether raising levels of HDL-cholesterol (the "good" cholesterol) can improve how blood vessels work in kidney disease. This may help us understand the causes leading to high rates of heart disease in kidney disease and also ways to reduce this risk.

Conditions

Interventions

TypeNameDescription
DRUGNiacin1000 mg tablets once per day
DRUGActive Placebo100 mg Niacin tablets once per day

Timeline

Start date
2008-08-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2009-02-27
Last updated
2014-05-06
Results posted
2014-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00852969. Inclusion in this directory is not an endorsement.

Niacin and Endothelial Function in Early CKD (NCT00852969) · Clinical Trials Directory